Prospective evaluation of upper extremity access and total transfemoral approach during fenestrated and branched endovascular repair

Copyright © 2023 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved..

OBJECTIVE: Total transfemoral (TF) access has been increasingly used during fenestrated-branched endovascular aortic repair (FB-EVAR). However, it is unclear whether the potential decrease in the risk of cerebrovascular events is offset by increased procedural difficulties and other complications. The aim of this study was to compare outcomes of FB-EVAR using a TF vs upper extremity (UE) approach for target artery incorporation.

METHODS: We analyzed the clinical data of consecutive patients enrolled in a prospective, nonrandomized clinical trial in two centers to investigate the use of FB-EVAR for treatment of complex abdominal aortic aneurysms (CAAA) and thoracoabdominal aortic aneurysms (TAAA) between 2013 and 2022. Patients were classified into TF or UE access group with a subset analysis of patients treated using designs with directional branches. End points were technical success, procedural metrics, 30-day cerebrovascular events defined as stroke or transient ischemic attack, and any major adverse events (MAEs).

RESULTS: There were 541 patients (70% males; mean age, 74 ± 8 years) treated by FB-EVAR with 2107 renal-mesenteric TAs incorporated. TF was used in175 patients (32%) and UE in 366 patients (68%) including 146 (83%) TF and 314 (86%) UE access patients who had four or more TAs incorporated. The use of a TF approach increased from 8% between 2013 and 2017 to 31% between 2018 and 2020 and 96% between 2021 and 2022. Compared with UE access patients, TF access patients were more likely to have CAAAs (37% vs 24%; P = .002) as opposed to TAAAs. Technical success rate was 96% in both groups (P = .96). The use of the TF approach was associated with reduced fluoroscopy time and procedural time (each P < .05). The 30-day mortality rate was 0.6% for TF and 1.4% for UE (P = .67). There was no early cerebrovascular event in the TF group, but the incidence was 2.7% for UE patients (P = .035). The incidence of MAEs was also lower in the TF group (9% vs 18%; P = .006). Among 237 patients treated using devices with directional branches, there were no significant differences in outcomes except for a reduced procedural time for TF compared with UE access patients (P < .001).

CONCLUSIONS: TF access was associated with a decreased incidence of early cerebrovascular events and MAEs compared with UE access for target artery incorporation. Procedural time was decreased in TF access patients irrespective of the type of stent graft design.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:79

Enthalten in:

Journal of vascular surgery - 79(2024), 5 vom: 19. Apr., Seite 1013-1023.e3

Sprache:

Englisch

Beteiligte Personen:

Mesnard, Thomas [VerfasserIn]
Vacirca, Andrea [VerfasserIn]
Baghbani-Oskouei, Aidin [VerfasserIn]
Sulzer, Titia A L [VerfasserIn]
Savadi, Safa [VerfasserIn]
Kanamori, Lucas Ruiter [VerfasserIn]
Tenorio, Emanuel R [VerfasserIn]
Mirza, Aleem [VerfasserIn]
Saqib, Naveed [VerfasserIn]
Mendes, Bernardo C [VerfasserIn]
Huang, Ying [VerfasserIn]
Oderich, Gustavo S [VerfasserIn]

Links:

Volltext

Themen:

Cerebrovascular event
Clinical Trial
Fenestrated-branched endovascular aortic repair
Journal Article
Major adverse events
Total transfemoral approach
Upper extremity access

Anmerkungen:

Date Completed 22.04.2024

Date Revised 22.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jvs.2023.12.033

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366323970